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Episodic memory recall processes in Alzheimer’s disease (AD) and behavioral variant
frontotemporal dementia (bvFTD) can be similarly impaired, whereas recognition
performance is more variable. A potential reason for this variability could be false-positive
errors made on recognition trials and whether these errors are due to amnesia per se or a
general over-endorsement of recognition items regardless of memory. The current study
addressed this issue by analysing recognition performance on the Rey Auditory Verbal
Learning Test (RAVLT) in 39 bvFTD, 77 AD and 61 control participants from two centers
(India, Australia), as well as disinhibition assessed using the Hayling test. Whereas both
AD and bvFTD patients were comparably impaired on delayed recall, bvFTD patients
showed intact recognition performance in terms of the number of correct hits. However,
both patient groups endorsed significantly more false-positives than controls, and bvFTD
and AD patients scored equally poorly on a sensitivity index (correct hits—false-positives).
Furthermore, measures of disinhibition were significantly associated with false positives
in both groups, with a stronger relationship with false-positives in bvFTD. Voxel-based
morphometry analyses revealed similar neural correlates of false positive endorsement
across bvFTD and AD, with both patient groups showing involvement of prefrontal
and Papez circuitry regions, such as medial temporal and thalamic regions, and a DTI
analysis detected an emerging but non-significant trend between false positives and
decreased fornix integrity in bvFTD only. These findings suggest that false-positive errors
on recognition tests relate to similar mechanisms in bvFTD and AD, reflecting deficits
in episodic memory processes and disinhibition. These findings highlight that current
memory tests are not sufficient to accurately distinguish between bvFTD and AD patients.
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INTRODUCTION
Alzheimer’s disease (AD) and behavioral variant frontotemporal
dementia (bvFTD) are the two most common early-onset
dementias (Ratnavalli et al., 2002). Revised diagnostic criteria
for both have been proposed, highlighting dysexecutive and
neuropsychiatric symptoms as hallmark features in bvFTD,
whereas a major feature of AD is pronounced impairment
in episodic memory (McKhann et al., 1984; Rascovsky et al.,
2007). However, recent studies have found significant memory
deficits in bvFTD patients, including those with pathological
confirmation and those in the early disease stages (Hornberger
et al., 2010; Irish et al., 2011, 2014; Pennington et al., 2011).
Conversely, AD patients occasionally present with executive
dysfunction and “frontal” behavioral features (McKhann et al.,
1984; Binetti et al., 1996). Thus, differentiating between bvFTD
and AD can be challenging considering these clinical overlaps
(Mendez et al., 1993; Varma et al., 1999).
Episodic memory processes have long been attributed to
the integrity of the hippocampus and supporting medial
temporal lobe (MTL) regions (Milner, 1970; Squire et al., 2004).
Hippocampal atrophy in particular is a hallmark feature of early
AD (Braak and Braak, 1991), and is considered to underpin the
prominent memory deficits in these patients (Leon et al., 1996;
Jack et al., 1997). Hippocampal changes have also been found
in early-stage bvFTD in terms of post-mortem pathology (Broe
et al., 2003; Kril and Halliday, 2004) and along with supporting
MTL structures in in vivo imaging studies (Seeley et al., 2008;
Whitwell et al., 2009; Hornberger et al., 2012), with the severity of
atrophy in these regions sometimes comparable to that found in
AD (van de Pol et al., 2006; Rabinovici et al., 2008; Pennington
et al., 2011). Beyond these MTL structures, a larger neural
network known as the Papez circuit has since been implicated in
memory processing. This circuit, in addition to the hippocampus,
consists of the fornix, mammillary bodies, anterior thalamus, and
cingulate cortex. Indeed, several of these regions have been found
to be compromised in both AD and bvFTD (Hornberger et al.,
2012; Irish et al., 2014), specifically the anterior cingulate and
thalamus in bvFTD, and posterior hippocampus and cingulate
cortex in AD. Furthermore, diffusion tensor imaging (DTI) has
been used to show the degeneration of the fornix in both AD
(Copenhaver et al., 2006; Mielke et al., 2009) and more recently
in bvFTD (Hornberger et al., 2012). The fornix is of particular
relevance as it links the MTL to ventromedial prefrontal areas via
the anterior commissure (Jay et al., 1992). Indeed, the episodic
memory deficits in bvFTD have also been linked to the prominent
prefrontal cortex (PFC) changes seen in these patients (Simons
et al., 2002b; Pennington et al., 2011), which is suggested to relate
specifically to deficits in the organization and implementation of
memory retrieval strategies rather than true amnesia or forgetting
of encoded material (Kramer et al., 2005). Memory deficits have
also been associated with PFC regions in AD (Wong et al., 2014),
but this prefrontal involvement has been suggested to be to a
lesser extent than in bvFTD (Pennington et al., 2011). Two recent
studies, however, indicate that bvFTD show impaired episodic
memory even after controlling for encoding performances and
semantic cueing of items to recall to compensate for PFC related
memory deficits (Bertoux et al., 2014; Lemos et al., 2014). As
such, it remains unclear as to how these structural changes in
the PFC and Papez memory circuit regions are related to the
neuropsychological profile of these patients.
On a behavioral level, AD patients exhibit accelerated
forgetting, which typically manifests as poor performance on
standard tests of free recall of previously learned material
following a time delay (de Toledo-Morrel et al., 2000). Recently,
bvFTD patients have also been found to show comparable
deficits on such measures of delayed free recall (Hornberger
et al., 2010; Ranjith et al., 2010; Pennington et al., 2011; Frisch
et al., 2013; Irish et al., 2014). Evidence therefore indicates
that recall performance is impaired in both diseases and that
it appears to rely on the integrity of both MTL and PFC
structures (Frisch et al., 2013; Irish et al., 2014). A different
picture emerges for performance on cued recall, or recognition
trials, for which bvFTD patients tend to perform better than
AD patients (Hornberger et al., 2010), and sometimes show no
impairment compared with healthy controls (Pasquier et al.,
2001; Harciarek and Jodzio, 2005; Hutchinson and Mathias,
2007; Ricci et al., 2012). This difference that emerges between
bvFTD and AD on recognition compared to free recall is
attributed to the cue enabling bvFTD patients to overcome
retrieval problems, and that the deficits in AD reflect a forgetting
of items. This relative improvement on recognition measures
between bvFTD and AD, however, appears variable, with some
reports of equal impairment between these groups (Ranjith et al.,
2010; Pennington et al., 2011; Irish et al., 2014). A possible
reason for this inconsistency could be that both bvFTD and
AD patients commit many false positive errors on recognition
trials (Pasquier et al., 2001; Ricci et al., 2012), such that
they incorrectly endorse many distractor items that were not
presented during the encoding phase of the test. Therefore, the
standard outcome measure of correct hits, or the number of
target items subjects correctly identified on recognition trials, is
unlikely to capture the underlying cause of memory deficits in
these patients. Indeed, the over-endorsement of distractor items
during recognition tasks could be either due to genuine amnesia
or disinhibited responding, or a combination of both. Exploring
this distinction between genuine amnesia and disinhibited
behavior in recognition memory in bvFTD and AD may reveal
critical differences between the recognition profiles in the two
diseases.
The current study directly addresses this issue by investigating
recognition performance on the Rey Auditory Verbal Learning
Test (RAVLT) in bvFTD compared to AD in a large, multi-center
sample. Importantly, to overcome the problem of false positive
errors obscuring true recognition performance, we introduced
a sensitivity index to account for false positives by subtracting
these errors from the total number of correct hits, using amethod
derived from recent similar papers investigating recognition
accuracy (Ricci et al., 2012). This approach was chosen to
increase the accuracy of true correct hit detection by removing
potential “noise” created from over-endorsement of distractor
items. In addition, we investigated gray and white matter atrophy
correlates of recognition false positive errors to elucidate whether
different prefrontal and memory circuit regions were responsible
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for these recognitionmemory performance patterns. Finally, data
were collected on the Hayling test (Burgess and Shallice, 1997),
a verbal test of inhibitory function, to determine whether these
false positive errors could be related to deficits in inhibitory
processes. Based on previous findings, we expected that both
bvFTD and AD patients would be impaired on delayed recall
measures. Similarly, we expected that both patient groups would
endorse a large number of false positives during the recognition
trials. We hypothesized, however, that recognition impairment
would reflect divergent cognitive mechanisms in each patient
group, with deficits in AD reflecting a pure amnesia in contrast
with a more disinhibited response style in the bvFTD group. As
such, we predicted that discrete gray and white matter neural
substrates would be associated with these deficits in each patient
group, with bvFTD patients showing significantly greater PFC
involvement, and AD patients showing greater involvement of
Papez circuit regions.
MATERIALS AND METHODS
Case Selection
Retrospective data from a total of 116 patients were used,
consisting of 39 bvFTD and 77 AD patients. Patient data were
sourced from the FRONTIERDementia Clinic, Sydney, Australia
(29 bvFTD, 37 AD), and the Department of Neurology and
Cognitive Neurology Unit, Apollo Gleneagles Hospital, Kolkata,
India (10 bvFTD, 40 AD). All bvFTD patients met current
consensus FTD diagnostic criteria, had imaging confirmation of
their diagnosis, and met criteria for probable bvFTD (Rascovsky
et al., 2011). We included bvFTD patients with memory deficits
if they fulfilled the other diagnostic criteria. Patients with
no evidence of disease progression and brain atrophy on
structural MRI were excluded to avoid potential non-progressive
phenocopy cases. All AD patients met NINCDS-ADRDA
diagnostic criteria (McKhann et al., 2011), with atypical cases
excluded when they presented with significantly predominant
visual or language deficits rather than memory impairment. A
sample of 61 healthy volunteers, including spouses and carers
of patients tested in Sydney (44) and India (18) served as
control participants. High-resolution T1 MR coronal images
were available for all participants from Sydney (n = 66).
Demographic, neuropsychological, and imaging data were taken
from the first clinical presentation of the patients.
The South Eastern Sydney Local Health District and the
University of New South Wales ethics committees, and the local
ethics committee for Apollo Gleneagles Hospitals approved the
study. Participants or their person responsible provided written
informed consent in accordance with the Declaration of Helsinki.
Neuropsychological Assessment
Severity of overall cognitive impairment was measured in
patients and controls using the Mini-Mental State Examination
(MMSE) (Folstein et al., 1983): a brief assessment of arithmetic,
memory, and orientation functioning scored out of a possible
30 points. Verbal learning and memory were assessed using the
Rey Auditory Verbal Learning Test (RAVLT) (Schmidt, 1996)
in English at both centers. The RAVLT consists of five learning
trials of 15 words, an interference trial of 15 words, followed by
immediate and 30-min delayed recall, and a 50 word recognition
trial including all 15 words from the learning trials, all 15
words from the interference trial, and 20 word semantically or
phonologically related to these two lists. Outcomes analyzed
include long term percent retention (LTPR), i.e., the percentage
of final learning recalled following a 30-minute delay (delayed
recall/learning trial 5 ∗ 100); number of correct hits in the
recognition trial; false positives, or number of words incorrectly
positively identified in the recognition trial; and a recognition
sensitivity index (correct hits—false positives) to account for
over-endorsement on recognition.
The Hayling Test (Burgess and Shallice, 1997) assesses
inhibition of a prepotent response by employing a sentence
completion task. In the first part of the test, participants are
required to complete a sentence with a single word that makes
sense, as quickly as they can. The second part of the test requires
the subject to complete sentences with single words that are
unconnected to the meaning of the sentence. Response times are
measured for both sections, as well as errors made in the second
section. Errors are categorized as either Category A errors, which
include words provided in the second section that meaningfully
complete the sentence, or Category B errors, which are words
that are semantically connected to words which meaningfully
complete the sentence. The measure of disinhibition from the
Hayling test used in this study was the total of both Category A
and Category B errors. The Hayling Test data were available for
Sydney patients only.
Neuroimaging
Image Acquisition and Voxel-Based Morphometry
(VBM) Analysis
All Sydney patients and controls underwent the same imaging
protocol with whole-brain T1-weighted images using a 3T
Phillips MRI scanner with a standard quadrature head coil
(8 channels). Imaging data were not available for analysis
from the Indian sample. The 3D T1-weighted sequences were
acquired as follows: coronal orientation, matrix 256 × 256, 200
slices, 1 × 1mm2 in-plane resolution, slice thickness 1mm,
TE/TR = 2.6/5.8ms, flip angle 8 degree. 3D T1-weighted
sequences were analyzed using FSL-VBM, a voxel-based
morphometry analysis (Ashburner and Friston, 2000; Good
et al., 2001), which is part of the FLS software package (http://
www.fmrib.ox.ac.uk/fsl/fslvbm/index.html) (Smith et al., 2004).
Following brain extraction from the images, tissue segmentation
was carried out using the FMRIB Automatic Segmentation Tool
(FAST) (Zhang et al., 2001). The resulting gray matter partial
volumemaps were aligned to theMontreal Neurological Institute
standard space (MNI52) using the nonlinear registration
approach with FNIRT (Andersson et al., 2007), which uses a
b-spline representation of the registration warp field (Rueckert
et al., 1999). To correct for local expansion or contraction,
the registered partial volume maps were modulated by dividing
them by the Jacobian of the warp field. The modulated images
were then smoothed with an isotropic Gaussian kernel with a
standard deviation of 2mm (FWHM: 8mm). Next, a voxel-wise
general linear model (GLM) was applied and permutation-based
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non-parametric testing (with 5000 permutations per contrast)
was used to form clusters with the Threshold Free Cluster
Enhancement (TFCE) method (Smith and Nichols, 2009). A ROI
mask for Papez memory circuit and prefrontal brain regions
was created using the Harvard-Oxford cortical and subcortical
structural atlas. The following atlas regions were included in the
mask: hippocampus, parahippocampal gyrus, temporal fusiform
gyrus, temporal pole, thalamus, mammillary bodies, cingulate
cortex, inferior frontal gyrus and orbitofrontal cortex.
As a first step, differences in gray matter intensities between
patients and controls were assessed (see Supplementary Table
1 for more details). For comparisons between patients and
controls, a threshold of 50 contiguous voxels was used, with
Family-wise Eror (FWE) correction at the p < 0.05 threshold.
Next, correlations between gray matter atrophy and RAVLT false
positives and Hayling AB error scores were entered as covariates
in the design matrix of the VBM analysis in separate analyses for
AD and bvFTD patients combined with controls. This procedure
has previously been used in similar studies including bvFTD and
AD patients (Irish et al., 2014) and serves to achieve greater
variance in behavioral scores, thereby increasing the statistical
power to detect brain-behavior relationships. Finally, an overlap
analysis was conducted to identify common regions of gray
matter atrophy correlating with both RAVLT false positives and
Hayling total error scores. For all covariate analyses, a threshold
of 50 contiguous voxels was used, uncorrected at the p < 0.001
threshold. Regions of significant atrophy were superimposed on
the MNI standard brain, with maximum coordinates provided in
MNI space. Areas of significant gray matter loss were localized
with reference to the Harvard-Oxford probabilistic cortical and
subcortical atlas.
Diffusion Tensor Imaging (DTI) Analysis
The DTI-weighted sequences were acquired as follows:
32 gradient direction DTI sequence (repetition time/echo
time/inversion time: 8400/68/90ms; b-value = 1000 s/mm2; 55
2.5-mm horizontal slices, end resolution: 2.5 × 2.5 × 2.5mm3;
field of view 240 × 240mm, 96 × 96 matrix; repeated twice).
Two DTI sequences were acquired for each participant, which
were in a first step then averaged and corrected for eddy current
distortions, and this averaged sequence was used for analysis.
Tract-based Spatial Statistics from FSL were used to perform a
skeleton-based analysis of white matter fractional anisotropy.
Fractional anisotropy maps of each individual subject were
eddy current corrected and co-registered using non-linear
registration using FNIRT to the MNI standard space using the
FMRIB58_fractional anisotropy template, which is available
as part of the FSL software. The template was sub-sampled at
2 × 2 × 2mm due to the coarse resolution of native DTI data
(i.e., 2.5 × 2.5 × 2.5mm). After image registration, fractional
anisotropy maps were averaged to produce a group mean
fractional anisotropy image. A skeletonization algorithm was
applied to the group mean fractional anisotropy image to
define a group template of the lines of maximum fractional
anisotropy, assumed to correspond to centers of white matter
tracts. Fractional anisotropy values for each individual subject
were then projected onto this group template skeleton. Clusters
were tested using permutation-based non-parametric testing
as described for the VBM analysis. Clusters reported have
significance at p < 0.05, corrected for multiple comparisons
across Family-Wise Error (FWE) correction space, unless
otherwise stated. Similar to the VBM analysis, a mask for the
regions of interest (fornix) was created based on the probabilistic
JHU White-Matter Tractography Atlas (Mori et al., 2005). The
DTI analysis first compared fornix integrity between bvFTD and
controls, AD and controls, and between patient groups. Fornix
integrity was then correlated with the false positive errors from
the RAVLT recognition trial.
Statistical Analysis
Clinical data were analyzed using IBM SPSS 20.0 (SPSS Inc.,
Chicago, IL). Preliminary analysis of distribution normality using
Kolmogorov-Smirnov tests revealed deviations from normal
distributions for all variables of interest, and as a result
non-parametric Kruskal-Wallis, Mann-Whitney and Chi-square
tests for group comparisons as well as Spearman’s rank-
order coefficient were used for between-group comparisons and
correlations where appropriate. Effect size for the comparison
between bvFTD and AD for the correct hits score on recognition
was also calculated using Cohen’s d, and percentage overlap
between the two groups was derived from this.
RESULTS
Demographics
Groups did not differ significantly in number of years of age or
education, and patient groups did not differ in disease duration
(p’s< 0.05). Chi-square analysis also showed no differences in sex
distributions between groups, (p > 0.05). Groups significantly
differed on MMSE, with post-hoc comparisons revealing that
both bvFTD and AD patients performed worse than controls
(p’s < 0.001). No significant differences between patient groups
were present (p’s > 0.05).
Neuropsychological Assessment
Table 1 depicts demographics and cognitive test performance
across all groups.
Comparisons across study centers (Sydney vs. Kolkata)
revealed no significant difference for any demographic (age, sex
distribution, education, disease duration) or RAVLT variables
(p’s > 0.05), however the MMSE was significant lower for both
bvFTD (p < 0.01) and AD patient groups in Kolkata (p < 0.001)
(Supplementary Table 2).
RAVLT
Overall group comparisons revealed significant differences on all
RAVLT measures (p’s < 0.001), as shown in Table 1. Post-hoc
comparisons showed that both patient groups performed worse
than controls on all RAVLT measures (p’s < 0.001) with the
exception of recognition, where bvFTD patients did not differ
from controls (p > 0.05). AD patients performed worse than
bvFTD patients on LTPR, and recognition, (p’s < 0.05). When
false positives were taken into account using the recognition
sensitivity index, both patient groups showed equally impaired
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TABLE 1 | Mean (SD) scores and comparisons between groups for demographics and cognitive tests.
bvFTD AD Control Overall bvFTD vs. AD bvFTD vs. control AD vs. control
N 39 77 61
Age 60.56 (7.54) 64.17 (8.25) 63.59 (6.54) n.s. – – –
Education (years) 12.28 (2.89) 12.65 (3.08) 13.14 (3.29) n.s. – – –
Sex (M/F) 26/13 42/35 30/31 n.s. – – –
Disease duration (months) 41.38 (27.73) 33.06 (27.15) – n.s. – – –
MMSE (/30) 24.18 (5.12) 21.96 (5.84) 29.13 (1.1) *** n.s. *** ***
LTPR (%) 52.34 (55.01) 19.80 (27.83) 85.36 (20.50) *** ** *** ***
RECOGNITION
Correct hits 11.89 (3.60) 10.44 (2.99) 13.60 (1.53) *** ** n.s. ***
False positives 12.47 (11.05) 12.60 (7.13) 1.89 (2.24) *** n.s. *** ***
Sensitivity index −0.58 (10.23) −2.16 (7.01) 11.71 (3.00) *** n.s. *** ***
Hayling errors 37.36 (27.82) 16.92 (17.70) 2.10 (3.53) *** n.s. *** ***
*indicates significant differences between groups using Mann-Whitney post-hoc tests; MMSE, Mini-Mental State Examination; LTPR, Long Term Percent Retention; Sensitivity Index,
Recognition correct hits minus false positives; *p < 0.05; **p < 0.01; ***p < 0.001; n.s., non-significant.
performance compared to controls (p’s < 0.001). Notably,
however, patient groups did not differ on the recognition
sensitivity index or number of false positives (p’s = 0.06 and
0.07, respectively). The same pattern of significance emerged
for all RAVLT outcomes when considering the Sydney sub-set
alone (Supplementary Table 3). An effect size calculation for the
comparison between bvFTD and AD across both centres for the
correct hits score on recognition produced a Cohen’s d of 0.4,
which corresponds to 72.6% overlap between the two groups.
The Hayling Test
In comparison to controls, both bvFTD and AD patients made
significantly more total errors on the Hayling test (p’s < 0.001),
with no significant difference between patient groups (p > 0.07)
(Table 1). Interestingly, the Hayling total errors correlated with
RAVLT-recognition false-positives in both bvFTD (R = 0.65,
p < 0.001) and AD, (R = 0.42, p = 0.012) but not in controls
(R= −0.06, p = 0.71).
Neuroimaging
VBMNeural Correlates of RAVLT-Recognition False
Positives
In AD patients combined with controls, false positives covaried
with regions of gray matter density in the right temporal pole,
orbitofrontal cortex and parahippocampal gyrus, as well as
left inferior frontal gyrus, hippocampus and thalamus (Table 2,
Figure 1A). False positives in bvFTD patients combined with
controls correlated with regions of gray matter density in
the parahippocampal gyrus bilaterally, as well as the right
hippocampus, thalamus, temporal pole, orbitofrontal cortex and
inferior frontal gyrus (Table 2, Figure 1B).
Neural Correlates of Disinhibition
To investigate neural correlates of disinhibition in AD and
bvFTD, Hayling total error scores were entered as covariates in
the design matrix of separate VBM analyses. In AD patients
combined with controls, Hayling total error scores correlated
with atrophy in the right temporal pole, orbitofrontal cortex,
parahippocampal gyrus, precuneus, posterior cingulate cortex
and hippocampus (Table 3, Figure 2A). In contrast, Hayling total
error scores in bvFTD patients combined with controls covaried
with regions of atrophy in the bilateral parahippocampal gyrus,
and hippocampus, left fusiform cortex, as well as right temporal
pole, orbitofrontal cortex, subcallosal cortex, medial prefrontal
cortex, paracingulate cortex, anterior and posterior cingulate
cortices, inferior frontal gyrus and thalamus (Table 3, Figure 2B).
Overlap Analysis
Next, we conducted an overlap analysis to investigate common
regions underlying false positives and disinhibition in AD and
bvFTD (Table 4). In bvFTD combined with controls, common
regions for false positives and Hayling total error scores
were identified in the hippocampus, orbitofrontal cortex and
inferior frontal gyrus (Table 4, Figure 3). No regions significantly
overlapped in the AD group combined with controls.
DTI
In the DTI analysis, a contrast between healthy controls and
patient groups revealed better fornix integrity in the control
group. A direct comparison of fornix integrity between patient
groups revealed that the bvFTD group showed significantly more
fornix degeneration than the AD group.
There was a trend between false-positive errors and decreased
fornix integrity in the bvFTD group (not combined with
controls) (r = 0.39, p = 0.06), however this was not statistically
significant. No other groups showed a significant or emerging
relationship between false positive errors and fornix integrity.
DISCUSSION
The aim of this study was to compare recognition profiles in
bvFTD and AD, with a view to establishing the cognitive and
neural mechanisms differentially contributing to recognition
impairments in these syndromes. Our findings indicate
significant overlap between these groups both clinically and
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TABLE 2 | VBM analyses showing brain regions in which gray matter intensity correlates significantly with RAVLT false positives in patient groups
combined with controls.
Regions Hemisphere (L/R) MNI Coordinates Number of voxels
X Y Z
bvFTD COMBINED WITH CONTROLS
Parahippocampal gyrus (anterior), hippocampus, R 34 −10 −26 277
Hippocampus, thalamus R 22 −32 −8 264
Parahippocampal gyrus (anterior) L −12 −16 −28 160
Orbitofrontal cortex, inferior frontal gyrus R 46 28 −6 134
Temporal pole R 34 6 −32 97
AD COMBINED WITH CONTROLS
Temporal pole, orbitofrontal cortex, parahippocampal gyrus (anterior) R 24 6 −24 184
Inferior frontal gyrus L −44 12 12 98
Hippocampus, thalamus L −28 −40 0 64
All results uncorrected at p < 0.001; only clusters with at least 50 contiguous voxels included. All clusters reported t > 3.90. MNI, Montreal Neurological Institute.
FIGURE 1 | VBM analyses showing brain regions in which gray matter intensity correlates significantly with RAVLT false positives in (A) AD patients
compared with controls and (B) bvFTD patients compared with controls. Colored voxels show regions that were significant in the analysis with p < 0.001
uncorrected, with a cluster threshold of 50 contiguous voxels. Clusters are overlaid on the MNI standard brain.
in terms of neural mechanisms, with suggestion of more
involvement of disinhibition and its associated neural regions
in bvFTD, and a slightly more amnestic profile in AD. More
specifically, despite the finding that bvFTD patients performed
at a similar level to controls in terms of correct hits on the
recognition test, the overlap between bvFTD and AD (72.6%)
prevents any accurate clinical distinction. Importantly, both
bvFTD and AD patients showed similarly high false recognition
rates in comparison to controls. Furthermore, the imaging
analysis revealed considerably overlapping regions of atrophy
that correlate with these false positives in bvFTD and AD, with
both groups showing the conjunct involvement of Papez circuit
and prefrontal regions.
In more detail, despite both bvFTD and AD patients showing
impairment on delayed recall, which is in line with past
investigations comparing these groups (Hornberger et al., 2010;
Ranjith et al., 2010; Pennington et al., 2011; Irish et al.,
2014), only AD patients showed significant deficits on the
standard recognition measure of correct hits, as well as showing
greater impairment on delayed recall. However, both AD and
bvFTD patients endorsed significantly more false positive errors
compared to healthy controls, which is a recurrent finding
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TABLE 3 | VBM analyses showing brain regions in which gray matter intensity correlates significantly with Hayling total error scores in patient groups
combined with controls.
Regions Hemisphere (L/R) MNI Coordinates Number of voxels
X Y Z
bvFTD COMBINED WITH CONTROLS
Temporal pole, parahippocampal gyrus (anterior), orbitofrontal cortex,
subcallosal cortex, medial prefrontal cortex paracingulate cortex,
anterior cingulate cortex, inferior frontal gyrus,
R 34 6 −32 3676
Fusiform cortex (anterior), parahippocampal gyrus (anterior),
hippocampus
L −36 −6 −32 493
Inferior frontal gyrus R 52 10 8 147
Parahippocampal gyrus (posterior), hippocampus L −14 −34 −8 113
Thalamus R 18 −10 10 75
Posterior cingulate cortex R 6 −50 22 69
AD COMBINED WITH CONTROLS
Temporal pole, parahippocampal gyrus (anterior), orbitofrontal cortex R 26 6 −28 322
Precuneus, posterior cingulate cortex R 6 −52 18 101
Parahippocampal gyrus (anterior), hippocampus R 28 −12 −34 65
All results uncorrected at p < 0.001; only clusters with at least 50 contiguous voxels included. All clusters reported t > 3.90. MNI, Montreal Neurological Institute.
FIGURE 2 | VBM analyses showing brain regions in which gray matter intensity correlates significantly with Hayling total errors in (A) AD patients
compared with controls and (B) bvFTD patients compared with controls. Colored voxels show regions that were significant in the analysis with p < 0.001
uncorrected, with a cluster threshold of 50 contiguous voxels. Clusters are overlaid on the MNI standard brain.
(Pasquier et al., 2001; Ricci et al., 2012). Although the standard
recognition outcome of correct hits was significantly higher
in bvFTD compared to AD, this distinction has poor clinical
significance due to the large overlap (72.6%) and was no longer
significant once false positives were accounted for using the
sensitivity index. These findings contribute to a growing body
of evidence which indicates that bvFTD patients can indeed
show considerable deficits across a range of memory measures
(Hornberger et al., 2010; Ranjith et al., 2010; Pennington et al.,
2011; Irish et al., 2014). The difference between the standard
recognition measure and the sensitivity index also highlights the
limited value of standard memory outcomes in explaining true
memory performance in these patients. Specifically, although
bvFTD patients showed a normal performance on correct hits,
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TABLE 4 | VBM results showing common regions of significant gray matter intensity decrease that correlate with RAVLT false positives and Hayling total
errors in bvFTD combined with controls.
Regions Hemisphere (L/R/B) MNI Coordinates Number of voxels
X Y Z
FALSE POSITIVES AND HAYLING TOTAL ERROR SCORES
Hippocampus R 22 −32 −8 222
Hippocampus R 34 −10 −26 186
Orbitofrontal cortex, inferior frontal gyrus R 46 28 −6 114
All results uncorrected at p < 0.001; only clusters with at least 50 contiguous voxels included. All clusters reported t > 3.90. MNI, Montreal Neurological Institute.
FIGURE 3 | VBM analyses showing brain regions in which gray matter intensity correlates significantly with both RAVLT false positives and Hayling
total errors in bvFTD combined with controls. Colored voxels show regions that were significant in the analysis with p < 0.001 uncorrected, with a cluster
threshold of 50 contiguous voxels. Clusters are overlaid on the MNI standard brain.
they were equally impaired as AD patients once false positive
errors were considered. When considered together, it appears
that bvFTD patients in particular endorse many extra words in
addition to those correctly identified.
Regarding the imaging analysis, there was considerable
overlap in neural correlates of false positive errors between
bvFTD and AD. Both groups showed involvement of Papez
circuit regions, particularly medial temporal and thalamic
structures, as well as PFC regions. This overlap corroborates
similar findings from studies relating neural regions to memory
recall performance (Irish et al., 2014). Contrary to the Irish et al.
study (Irish et al., 2014) however, there was less of a distinction
between anterior and posterior network involvement in bvFTD
and AD, respectively—although the current study used a ROI
approach compared to the whole brain analysis conducted by
Irish and colleagues. However, another possible reason for this
is that the false positive errors would be underpinned more
strongly by source memory deficits and selecting the correct
information to retrieve, which in addition to being linked to
frontal atrophy (Simons et al., 2002a), particularly the OFC
(Collette and Van der Linden, 2002), has also been associated
with MTL regions (Söderlund et al., 2008). However, it should
also be noted that the AD patients in this sample were age-
matched to the bvFTD group, such that many of the AD patients
would be considered to belong to the early-onset form of AD.
It has previously been shown that, in comparison to later-onset
AD, these patients can have a pattern of neural atophy which is
less restricted to the characteristic MTL regions. Overall, these
findings suggest a reciprocal relationship between prefrontal
and Papez circuit regions, particularly between the MTL and
PFC, reflecting possible deficits in both memory retention and
retrieval. Taken together with the behavioral data, these retrieval
deficits could specifically reflect poor inhibition of incorrect
responses on recognition, particularly in the bvFTD group.
We explored this hypothesis further by investigating the
relationship between false positive errors and disinhibition errors
on the Hayling test, a validated test of verbal inhibition. These
two outcomes correlated in both patient groups, but when
taking the correlation coefficient as a measure of effect size,
the link between false positive errors and desinhibition was
stronger in bvFTD. However, it should also be noted that bvFTD
patients were slightly more impaired on the Hayling, although
this difference did not reach significance, nonetheless this could
have contributed to the strength of its relationship with false
positive errors between groups. On a neuroanatomical level, our
imaging findings fit with previous studies, showing ventromedial
prefrontal and anterior temporal involvement linked to the
disinhibition errors in bvFTD (Hornberger et al., 2011); however,
the current study also showed MTL and thalamic involvement
in both patient groups for this measure. Taken together, this
strongly suggests that poor inhibition of retrieving or endorsing
incorrect items made on recognition was related to poor memory
performance to a greater extent in bvFTD, in addition to memory
deficits. However, this was also present, albeit to a lesser degree, in
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AD patients, highlighting PFC involvement in false recognition
suppression in this group in line with suggestions from previous
findings (Budson et al., 2002). Taken together, these findings
suggest a considerable overlap in mechanisms underlying the
false positive errors in bvFTD and AD, with a slight double
dissociation of greater disinhibition in bvFTD and memory
deficits in AD.
This study involved a large sample size, with behavioral data
from multiple studies, that allowed us to reach good statistical
power for the behavioral analysis of the recognition performance
in bvFTD and AD, as compared to previous quantitative
investigations of memory performance between bvFTD and AD.
Delineation of correct hits and false positive errors on the
recognition trial using the sensitivity index allowed us to explore
specific memory impairment in both diseases. Finally, we used
a multimodal imaging analysis (VBM and DTI) to explore the
differential gray and white matter correlates of false positive
recognition and disinhibition. Despite these strengths, a potential
limitation of this study that pathological data were not available
for the bvFTD patients and as such, it remains unclear whether
any of this sample had underlying AD pathology. Furthermore,
there were no Hayling test or imaging data available for the
Indian sample, so several of the critical analyses could only be
conducted on the Sydney sample. However, participants were
matched between both centers for all other variables, including
RAVLT scores, with MMSE as the only exception. The use of
data from two centers also calls into question the consistency
between sites in terms of diagnostic accuracy; however diagnoses
were made in expert centers with a multi-disciplinary approach
and according to the same consensus criteria (McKhann et al.,
2011; Rascovsky et al., 2011). Also, the clinical progression over
a minimum 12 months follow-up was in accordance of the
initial diagnosis for all patients. Finally, our results did not
allow for us to investigate structured vs. unstructured recall,
which would be a worthwhile direction for future investigations.
Future investigations would also benefit from incorporating post-
mortem confirmation of pathology or in vivo investigation of AD
pathology using techniques such as amyloid PET imaging or CSF
biomarkers.
These findings have clinical significance. The behavioral
results from this study corroborate findings from a growing
body of evidence suggesting that performance on standard
memory tests does not adequately distinguish bvFTD from
AD (Hornberger et al., 2010; Ranjith et al., 2010; Pennington
et al., 2011; Irish et al., 2014). It particularly calls into question
the inclusion of “relative sparing of episodic memory” as
a diagnostic criterion for bvFTD (Rascovsky et al., 2011),
considering that we and others (Hornberger et al., 2010,
2012; Ranjith et al., 2010; Pennington et al., 2011; Irish
et al., 2014) have demonstrated that memory deficits in these
patients share some similarities with those observed in AD,
in terms of severity and underlying neural processes. Novel
findings from this study call into question the suitability
of standard memory measures, particularly recognition, to
adequately reflect memory deficits and differentiate between
bvFTD and AD. The correct diagnosis of these diseases is
important in terms of differing treatment and management
implications. As such, the reliance on memory performance in
the clinic to distinguish these groups may not be sufficient.
There is emerging evidence that other domains such as spatial
orientation (Tu et al., 2015) and social cognition (Bertoux et al.,
2015) are very reliable for distinguishing bvFTD from AD,
and these tests can be very easily administered in a clinical
setting. Our findings also have theoretical implications regarding
our understanding of the prefrontal involvement in memory
dysfunction, particularly in bvFTD, such that the characteristic
disinhibited profile of these patients might also contribute to
poor performance on memory measures in addition to an
amnesia similar to AD. As such, development of tests that can
disentangle such contributions to memory impairment in bvFTD
and AD is recommended, in order to improve upon existing
memory measures and better distinguish between these patient
groups.
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